Results for tag: "Selegiline"

Selegiline is a drug used to treat central nervous system disorders, such as Parkinson's disease, depression, and Alzheimer's disease. It is a monoamine oxidase inhibitor (MAOI) that works by increasing the levels of certain neurotransmitters in the brain, such as dopamine and norepinephrine. Selegiline is available in both oral and transdermal forms, and is often used in combination with other medications. The selegiline market is a growing one, with an increasing demand for the drug due to its effectiveness in treating a variety of neurological disorders. The market is expected to continue to grow in the coming years, as more people are diagnosed with neurological disorders and the need for effective treatments increases. Some of the major companies in the selegiline market include Pfizer, Novartis, Merck, and Teva Pharmaceuticals. These companies are involved in the research, development, and production of selegiline, as well as the marketing and distribution of the drug. Show Less Read more